Personalized medicine - Part 1: Evolution and development into theranostics

P and T

Volumn 35, Issue 10, 2010, Pages

  Vogenberg, F Randy ^a,b,c   Barash, Carol Isaacson ^d   Pursel, Michael ^e  

^a Institute for Integrated Healthcare   (United States)

^b JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d Genetics Ethics and Policy Consulting Inc   (United States)

^e Teva Neuroscience Inc   (United States)

Author keywords

Gene testing; Human genome; Personal genomics; Personalized medicine; Pharmacodiagnostics; Pharmacogenetics; Pharmacogenomics; Theranostics

Indexed keywords

CLINICAL PRACTICE; DRUG RESPONSE; GENE MAPPING; GENETIC SCREENING; HEALTH CARE COST; HUMAN; HUMAN GENOME; MEDICAL CARE; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOGENOMICS; PHARMACY BENEFIT MANAGER; PRESCRIPTION; REVIEW;

EID: 78149328298     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Mancinelli L, Cronin M, Sadee W. Pharmacogenomics: The promise of personalized medicine. AAPS Pharm Sci 200;2(1):E4.
2. Pharmacogenomics: When medicine gets personal. Available at: www.mayoclinic.com/health/personalized-medicine/CA00078. Accessed March 23, 2010.
3. Haile LA. Making personalized medicine a reality. Genetic Eng News 2008;28(1).
4. Leavitt MO, Kucherlapati R. The great promise of personalized medicine (opinion). Boston Globe, December 26, 2008.
5. American Clinical Laboratory Association. Results for Life: Lab Testing: Better Health for Improved Outcomes. Available at www.labresultsforlife.org.
6. Personalized Medicine E-Symposium (archived). Available at: www.pharmacogenomicsociety.org.
7. FDA Unveils Critical Path Opportunities List Outlining Blueprint to Modernizing Medical Product Development by 2010. March 16, 2006. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108619.htm.
8. Guidance for Industry and FDA Staff. Pharmacogenomics Tests and Genetic Tests for Heritable Markers. June 19, 2007; draft guidance issued on February 9, 2006. Available at: www.fda.gov/downloads/Medical Devices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm 071075.pdf.
9. Health Information Technology Leadership Panel: Final Report. Lewin Group. Available at: www.hhs.gov/ healthit/ HITFinalReport.pdf.
10. Evaluation of Genomic Applications in Practice and Prevention (EGAPP). Available at: www.egappreviews.org.
11. Genomics at FDA: Guidances, Concept Papers, and MaPPs [Manual of Policies and Procedures]. Available at: www.fda.gov/Drugs/ ScienceResearch/ ResearchAreas/Pharmacogenetics/ucm083374.htm.
12. Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS). Office of Biotechnology Activities. Available at: http://oba.od.nih.gov/ SACGHS/sacghs- home.html.
13. Pharmacogenetics Research Network, National Institute of General Medical Science. Available at: www.nigms.nih.gov/Initiatives/PGRN.
14. Understanding Health Information Privacy. Available at: www.hhs.gov/ocr/privacy/hipaa/understanding/index.html.
15. Chisholm R. What is Personalized Medicine? 2010 Science in Society. Available at: http://scienceinsociety.northwestern.edu/content/articles/2008/ what-is-personalized-medicine?gclid=clatmksg-aecfufm5qodbhzifg.
16. The Impact of Personalized Medicine Today. HealthLeaders Media, April 30, 2010. Available at: www.healthleadersmedia.com/content/led-250352/The-Impact- of-Personalized-Medicine-Today-60k.